Skip to main content

GENELUX Corp

GNLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001231457

In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding GENELUX Corp changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of GNLX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders6773+6
Shares6.02M7.09M+1.07M (+17.8%)
Value$38.8M$14.0M−$24.8M (−64.0%)

New holders (26)

Institutions that held GENELUX Corp at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to GNLX in Q2 2024
InstitutionSharesValue% of portfolio
Armistice Capital, LLC900,000$1.75M0.05%
Highbridge Capital Management LLC631,307$1.23M0.05%
Affinity Asset Advisors, LLC100,000$195.0K0.03%
Y-Intercept (Hong Kong) Ltd80,350$156.7K0.01%
Susquehanna International Group, LLP73,858$144.0K0.00%
Jane Street Group, LLC73,174$142.7K0.00%
Two Sigma Investments, LP39,715$77.4K0.00%
Squarepoint Ops LLC38,264$74.6K0.00%
Centiva Capital, LP37,700$73.5K0.00%
Miracle Mile Advisors, LLC30,000$58.5K0.00%
Cubist Systematic Strategies, LLC28,663$55.9K0.00%
Qube Research & Technologies Ltd27,875$54.4K0.00%
HRT Financial LP27,434$53.0K0.00%
Point72 Asia (Singapore) Pte. Ltd.20,162$39.3K0.01%
Commonwealth Equity Services, LLC13,112$26.0K0.00%
Schonfeld Strategic Advisors LLC13,200$25.7K0.00%
Ground Swell Capital, LLC10,808$21.1K0.02%
Warberg Asset Management LLC10,000$20.0K0.01%
Mirae Asset Global ETFs Holdings Ltd.9,762$19.0K0.00%
Point72 (DIFC) Ltd5,752$11.2K0.00%
Catalyst Funds Management Pty Ltd4,800$9.36K0.00%
Coppell Advisory Solutions LLC3,001$5.85K0.00%
Russell Investments Group, Ltd.1,302$2.54K0.00%
Macquarie Group Ltd973$1.90K0.00%
Allspring Global Investments Holdings, LLC77$1500.00%
Capital Advisors, Ltd. LLC96$00.00%

Sold out (20)

Institutions that held GENELUX Corp at the end of Q1 2024 and filed for Q2 2024 without it.